Change over period: —
NSE · ALEMBICLTD
ALEMBIC LTD.
-2.8% from the 52-week high · +58.5% above the low
Alembic Ltd. engages in the pharmaceutical and real estate business. The company is headquartered in Vadodara, Gujarat and currently employs 305 full-time employees. The firm operates through a single segment, Pharmaceuticals. The Pharmaceuticals segment is engaged in the manufacturing and marketing of fermentation and chemistry-based Active Pharmaceuticals Ingredients (API). The firm is also engaged in research and development activity at Vadodara. The firm manufactures/provides three key products/services: Azithromycin, Venlafaxine and Telmisartan.
The short version. ALEMBIC LTD. reported revenue of ₹30 crore for Sep 2026, down 46.4% from a year earlier. Net profit was ₹163 crore (up 27.3% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 71.41% in Sep 2026, up 0.53 points over 8 quarters.
1 · The price
How has the stock traded?
ALEMBIC LTD. trades 2.8% below its 52-week high and 58.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹30 cr.
Sep 2026 net profit of ₹163 cr.
308.5 pts higher than a year earlier.
Revenue compounded at 17.8% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 30 | 49 | 60 | 74 | 56 | 50 | 60 | 58 |
| Net profit | 163 | 65 | 67 | 60 | 128 | 62 | 68 | 65 |
| Net margin % | 538.5 | 133.1 | 111.8 | 80.9 | 230.0 | 123.9 | 113.6 | 112.9 |
| EPS (₹) | 6.34 | 2.53 | 2.61 | 2.34 | 5.0 | 2.4 | 2.67 | 2.55 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 240 | 222 | 157 | 127 | 78 | 74 | 74 | 128 |
| Net profit | 317 | 311 | 269 | 191 | 222 | 343 | 329 | 230 |
| Net margin % | 132.2 | 140.0 | 170.6 | 149.8 | 283.9 | 466.4 | 445.2 | 180.4 |
| EPS (₹) | 12.36 | 12.1 | 10.46 | 7.42 | 8.65 | 13.35 | 12.82 | 8.97 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 13.0% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 13.0 | 13.3 | 12.3 | 9.2 |
| Return on capital % | 6.1 | 6.6 | 4.6 | 4.1 |
| EBITDA margin % | 52.2 | 56.8 | 52.6 | 49.1 |
| Net margin % | 101.4 | 104.7 | 126.6 | 99.6 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 17.8% | 30.1% |
| Profit CAGR | 18.5% | -1.5% |
4 · The owners
Who holds it, and are they adding?
Up 0.53 pts over 8 quarters.
Down 0.44 pts over 8 quarters.
Down 0.01 pts over 8 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.88 | 70.88 | 70.88 | 70.88 | 70.88 | 70.88 | 70.88 | 71.41 | +0.53 |
| FII | 1.78 | 1.66 | 1.5 | 1.38 | 1.28 | 1.25 | 1.25 | 1.34 | -0.44 |
| DII | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | -0.01 |
| Public | 27.27 | 27.41 | 27.57 | 27.69 | 27.78 | 27.82 | 27.81 | 27.2 | -0.07 |
Mutual fund holdings · Oct 2026
1 scheme hold this stock
0 the month before.
- HDFC BSE REITS and Commercial Real Estate Index Fund0.2% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ALEMBIC LTD. are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Realty stocks
Quick answers
Common questions about ALEMBIC LTD.
What is the ALEMBIC LTD. share price?
ALEMBIC LTD. (ALEMBICLTD) last closed at ₹111.41, down 0.89% on the day. Its 52-week range is ₹70.90 to ₹115.67.
What is the market cap of ALEMBIC LTD.?
ALEMBIC LTD. has a market capitalisation of about ₹2,889 crore. Its price-to-earnings ratio is 8.2.
How are ALEMBIC LTD.'s latest results?
ALEMBIC LTD. reported revenue of ₹30 crore for Sep 2026, down 46.4% from a year earlier. Net profit was ₹163 crore (up 27.3% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 71.41% in Sep 2026, up 0.53 points over 8 quarters.
Who owns ALEMBIC LTD.?
As of Sep 2026, shareholding was: Promoter 71.41%, FII 1.34%, DII 0.05%, Public 27.2%.
How many mutual funds hold ALEMBIC LTD.?
1 mutual fund schemes held ALEMBIC LTD. in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 05 Aug 2025 · Final Dividend - Rs. 2.4
- 05 Aug 2024 · Final Dividend - Rs. 2.4
- 03 Aug 2023 · Final Dividend - Rs. 2.2
- 12 Sep 2022 · Dividend - Rs. 1.8
- 29 Jul 2021 · Final Dividend - Rs. 0.2
- 29 Jul 2020 · Final Dividend - Rs. 0.6
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.